Total Payments
$68,765
2024 Payments
$23,479
Companies
13
Transactions
85
Medicare Patients
932
Medicare Billing
$111,313
Payment Breakdown by Category
Consulting$39,885 (58.0%)
Other$22,058 (32.1%)
Travel$4,262 (6.2%)
Food & Beverage$2,560 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $39,885 | 17 | 58.0% |
| Honoraria | $17,040 | 6 | 24.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,700 | 3 | 6.8% |
| Travel and Lodging | $4,262 | 17 | 6.2% |
| Food and Beverage | $2,560 | 41 | 3.7% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $318.36 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Deciphera Pharmaceuticals Inc. | $17,369 | 19 | $0 (2024) |
| Daiichi Sankyo Inc. | $12,366 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,224 | 12 | $0 (2024) |
| Janssen Products, LP | $7,609 | 11 | $0 (2017) |
| Aadi Bioscience, Inc. | $7,028 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $6,386 | 8 | $0 (2023) |
| SpringWorks Therapeutics, Inc. | $2,466 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,950 | 1 | $0 (2021) |
| Lilly USA, LLC | $550.00 | 1 | $0 (2018) |
| Puma Biotechnology, Inc. | $318.36 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,479 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($12,224) |
| 2023 | $2,273 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($1,500) |
| 2022 | $7,110 | 10 | Aadi Bioscience, Inc. ($6,952) |
| 2021 | $8,903 | 5 | Deciphera Pharmaceuticals Inc. ($4,853) |
| 2020 | $6,525 | 2 | Deciphera Pharmaceuticals Inc. ($3,300) |
| 2018 | $3,766 | 9 | Bayer HealthCare Pharmaceuticals Inc. ($2,786) |
| 2017 | $16,708 | 23 | Daiichi Sankyo Inc. ($8,891) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $595.00 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Honoraria | Cash or cash equivalent | $3,330.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $47.50 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Consulting Fee | Cash or cash equivalent | $595.00 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,140.00 | General |
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $140.00 | General |
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $119.50 | General |
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $101.07 | General |
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $115.41 | General |
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 07/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.42 | General |
| 07/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $243.33 | General |
| 07/08/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $59.77 | General |
| Category: Cancer | ||||||
| 06/28/2024 | Aadi Bioscience, Inc. | Fyarro (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cancer | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $272.03 | General |
| 06/02/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $92.25 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2024 | Deciphera Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $585.00 | General |
| 04/27/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Honoraria | Cash or cash equivalent | $2,340.00 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Travel and Lodging | In-kind items and services | $492.20 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2024 | Deciphera Pharmaceuticals Inc. | VIMSELTINIB (Drug) | Travel and Lodging | In-kind items and services | $242.57 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 202 | 310 | $86,691 | $24,366 |
| 2022 | 5 | 231 | 362 | $101,088 | $28,969 |
| 2021 | 6 | 236 | 308 | $94,884 | $27,492 |
| 2020 | 7 | 263 | 433 | $124,879 | $30,486 |
Total Patients
932
Total Services
1,413
Medicare Billing
$111,313
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 58 | 99 | $25,245 | $6,739 | 26.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 42 | 42 | $20,580 | $5,468 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 50 | $17,200 | $5,130 | 29.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 41 | $10,250 | $3,572 | 34.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 62 | 78 | $13,416 | $3,457 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 88 | $22,000 | $6,948 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 41 | 62 | $21,328 | $6,461 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 59 | 88 | $22,440 | $6,155 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 44 | 44 | $21,560 | $5,872 | 27.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 64 | 80 | $13,760 | $3,533 | 25.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 49 | 73 | $25,112 | $7,898 | 31.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 55 | 55 | $26,950 | $7,583 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 100 | $25,500 | $7,070 | 27.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 29 | $7,250 | $2,308 | 31.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 32 | 38 | $6,536 | $1,562 | 23.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 13 | 13 | $3,536 | $1,072 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 97 | 179 | $45,645 | $9,553 | 20.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 38 | 121 | $30,250 | $8,762 | 29.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 42 | 42 | $20,626 | $5,063 | 24.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 27 | 32 | $11,300 | $2,563 | 22.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $7,290 | $1,973 | 27.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 22 | 22 | $5,984 | $1,711 | 28.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 22 | 22 | $3,784 | $860.62 | 22.7% |
About Dr. Richard Riedel, MD
Dr. Richard Riedel, MD is a Internal Medicine healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235227844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Riedel, MD has received a total of $68,765 in payments from pharmaceutical and medical device companies, with $23,479 received in 2024. These payments were reported across 85 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($39,885).
As a Medicare-enrolled provider, Riedel has provided services to 932 Medicare beneficiaries, totaling 1,413 services with total Medicare billing of $111,313. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Durham, NC
- Active Since 10/10/2006
- Last Updated 10/10/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1235227844
Products in Payments
- QINLOCK (Drug) $13,390
- YONDELIS (Drug) $7,609
- FYARRO (Drug) $6,952
- VIMSELTINIB (Drug) $3,394
- Turalio (Drug) $3,383
- Non-Covered $2,786
- Vitrakvi (Drug) $2,100
- Stivarga (Drug) $1,500
- Nerlynx (Drug) $318.36
- VOTRIENT (Drug) $236.61
- OGSIVEO (Drug) $226.36
- ALIYA SYSTEM (Device) $178.18
- Vanflyta (Drug) $92.25
- CYRAMZA (Drug) $84.10
- Fyarro (Drug) $75.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Durham
Nirmish Shah, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Stephen Greene, M.d, M.D
Internal Medicine — Payments: $509,299
Internal Medicine $509,299
Dr. Robert Mentz, Md, MD
Internal Medicine — Payments: $466,052
Internal Medicine $466,052
Dr. John Strickler, Md, MD
Internal Medicine — Payments: $314,904
Internal Medicine $314,904
Dr. Kevin Thomas, Md, MD
Internal Medicine — Payments: $294,767
Internal Medicine $294,767
Dr. Manesh Patel, M.d, M.D
Internal Medicine — Payments: $289,122
Internal Medicine $289,122